Fundamentals

Valuation

Metric	Q1	Q2	Δ in %
EV/EBITDA	29.88	-10.78	-15.37
Graham Fair Price	41.42	2.02	1.43
PEG	-77.45	-0.05	0.22
Price/Book	21.00	0.42	0.34
Price/Cash Flow	59.04	-5.40	-13.18
Prices/Earnings	39.50	-4.84	-7.99
Price/Sales	-39.50	1.46	2.41
Price/FCF	59.04	-5.40	-13.18
Naive Interpretation	member

01 - Valuation · Somewhat Weak

Fundamentals

Profitability

Metric	Q1	Q2	Δ in %
Gross Profit Margin	0.00	0.08	0.08
Operating Margin	0.00	-0.09	-0.09
ROA	-100.00	-0.02	< 0.005
ROE	-0.01	-0.02	-100.00
ROIC	-0.01	-0.03	-100.00
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q1	Q2	Δ in %
Debt QOQ	0.00	-0.16	inf
Dividends QOQ	0.00	0.00	0.00
EBIT QOQ	0.69	-1.00	45.32
EPS QOQ	0.37	-1.00	168.33
FCF QOQ	-3.07	-1.95	36.39
Revenue QOQ	-0.17	1.00	480.81
Naive Interpretation	member

03 - Financial Growth · Positive

Fundamentals

Leverage & Liquidity

Metric	Q1	Q2	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	32.46	16.23	-50.00
Days Sales Outstanding (DSO)	100.17	57.14	-42.96
Inventory Turnover	2.77	5.55	100.00
Debt/Capitalization	0.01	0.01	0.00
Quick Ratio	2.85	2.95	3.46
Naive Interpretation	member

04 - Leverage & Liquidity · Weak

Fundamentals

Per Share Metrics

Metric	Q1	Q2	Δ in %
Book Value	2.90	2.90	< 0.005
Cash	1.54	1.55	0.29
Capex	0.00	-0.10	-100.00
Free Cash Flow	-0.08	-0.22	-195.44
Revenue	0.41	0.83	100.00
Naive Interpretation	member

05 - Per Share Metrics · Positive

Fundamentals

Financial Health

Metric	Q1	Q2	Δ in %
Current Ratio	3.17	3.17	0.00
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	13.67	6.86	-49.80
Naive Interpretation	Member

06 - Financial Health · Bad

Rating